Top compounds associated with response to RP11-729L2.2


Feature Type Standardized
Nominal ANOVA
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA methylstat CTRPv2 pan-cancer AAC 0.2 7e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA ISOX CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA vincristine CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.13 2e-05
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.16 2e-05
Download CSV